Please ensure Javascript is enabled for purposes of website accessibility Global Life Sciences Fund - Janus Henderson Investors
For Individual Investors in the US

JNGLX Global Life Sciences Fund

The fund/portfolio seeks to harness the rapid innovation in health care to generate returns by investing in companies addressing unmet medical needs or those that seek to make the health care system more efficient.

NAV
$79.58
As of 07/12/2024

1-Day Change
$0.83 (1.05%)
As of 07/12/2024

YTD Return
15.12%
As of 07/12/2024

Morningstar Rating

As of 06/30/2024

Overview

ABOUT THIS FUND

The fund seeks to harness the rapid innovation in health care to generate returns by investing in companies addressing unmet medical needs or those that seek to make the health care system more efficient.

WHY INVEST IN THIS FUND

Health Care Expertise: Our domain experts have 95+ years of combined experience investing in the complex and dynamic health care sector. Our team of specialists, which include multiple Ph.D.’s, seek to understand both the science and the business of prospective investments.

Balanced Approach: We diversify the portfolio across market capitalizations, geographies and the primary sub-sectors of health care, including investments in biotechnology, health care services, medical devices and pharmaceuticals.

Integrated Risk Management Process: Security-level “Value at Risk” framework focuses attention on downside risks by limiting the position size of higher-risk stocks.

PORTFOLIO MANAGEMENT

Andy Acker, CFA

Portfolio Manager

Industry since 1996. Joined Firm in 1999.

Daniel Lyons, Ph.D., CFA

Portfolio Manager | Research Analyst

Industry since 2000. Joined Firm in 2000.

Performance

RETURNS (%) (As of 06/30/2024)
Global Life Sciences Fund - D Shares MSCI World Health Care IndexSM S&P 500® Index
 
3M YTD 1YR 3YR 5YR 10YR Since Inception
(12/31/1998)
Global Life Sciences Fund - D Shares 1.93 10.66 15.13 5.85 11.50 11.20 11.51
MSCI World Health Care IndexSM 0.48 7.99 11.17 4.92 10.10 8.73 6.91
S&P 500® Index 4.28 15.29 24.56 10.01 15.04 12.86 8.01
RETURNS (%) (As of 06/30/2024)
Global Life Sciences Fund - D Shares MSCI World Health Care IndexSM S&P 500® Index
 
3M YTD 1YR 3YR 5YR 10YR Since Inception
(12/31/1998)
Global Life Sciences Fund - D Shares 1.93 10.66 15.13 5.85 11.50 11.20 11.51
MSCI World Health Care IndexSM 0.48 7.99 11.17 4.92 10.10 8.73 6.91
S&P 500® Index 4.28 15.29 24.56 10.01 15.04 12.86 8.01
Calendar Year Returns (%)
Global Life Sciences Fund - D Shares MSCI World Health Care IndexSM
2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Global Life Sciences Fund - D Shares 7.50 -2.70 6.82 25.55 29.20 4.34 22.59 -12.32 8.32 34.97
MSCI World Health Care IndexSM 3.76 -5.41 19.80 13.52 23.24 2.51 19.80 -6.81 6.60 18.10

GROWTH OF A HYPOTHETICAL INVESTMENT

Global Life Sciences Fund - D Shares MSCI World Health Care IndexSM Health

RETURNS-BASED STATISTICS (As of 06/30/2024 Class I Shares)

RISK / REWARD
VS. MSCI World Health Care NR Index
3YR 5YR
Information Ratio 0.17 0.21
Alpha 1.07 1.39
Tracking Error 5.59 6.41
Beta 1.02 1.02
R-squared (%) 87.53 83.98
UP/DOWN MARKET CAPTURE (%)
VS. MSCI World Health Care NR Index
3YR 5YR
Up Capture Ratio 103.90 103.78
Down Capture Ratio 99.30 97.34
STANDARD DEVIATION 3YR 5YR
Global Life Sciences Fund 15.60 15.96
MSCI World Health Care NR Index 14.28 14.32
SHARPE RATIO 3YR 5YR
Global Life Sciences Fund 0.17 0.57
MSCI World Health Care NR Index 0.12 0.54
ANNUAL FEES & EXPENSES (As of the most recent prospectus)
CLASS D SHARES
Management Fees 0.64%
Other Expenses 0.16%
Total Gross Expenses 0.80%
Total Net Expenses 0.80%

Portfolio

Index represents the MSCI World Health Care Index.

Top Holdings (As of 05/31/2024)
% of Fund
Eli Lilly & Co 8.56
UnitedHealth Group Inc 6.06
Novo Nordisk A/S 5.83
AstraZeneca PLC 3.81
AbbVie Inc 3.47
Merck & Co Inc 3.45
Amgen Inc 2.74
Sanofi SA 2.50
Boston Scientific Corp 2.46
Vertex Pharmaceuticals Inc 2.42
TOTAL 41.30
View full holdings
Portfolio Characteristics (As of 05/31/2024)
  FUND INDEX
Number of Holdings
Equity Issues
119 137
Market Capitalization
Weighted Average
$193.69B $219.86B
Portfolio Turnover Rate
(1-year trailing)
33.34% -
Price/Earnings Ratio
(1-year forward)
20.01 18.45
Price/Book Ratio
5.10 4.40
Earnings Growth Rate
(1-year forward)
23.21% 19.36%
Sector Allocation % of Fund % of Index % of Fund % of Index As of 05/31/2024
Regional Allocation % of Fund % of Index % of Fund % of Index As of May 31, 2024
Developed vs Emerging Markets % of Fund % of Index % of Fund % of Index As of May 31, 2024
Market Capitalization Range of Equity Holdings % of Fund % of Index % of Fund % of Index As of 05/31/2024

Documents